Chinese researchers identify biomarker for early detection of AD
Chinese researchers have identified a neuroimaging biomarker that can facilitate the early detection of Alzheimer's disease (AD).
AD is a chronic neurodegenerative disease characterized by progressive dementia. Neuroimaging techniques such as magnetic resonance imaging (MRI) can help diagnose AD. Accurate data-driven methods that can classify and characterize the neural features of AD would be powerful clinical tools.
Researchers from the Institute of Automation of the Chinese Academy of Sciences and other collaborators found that hippocampal radiomic features can be a promising personalized biomarker for AD.
In their search for suitable biomarkers, researchers proposed a novel hippocampal radiomic biomarker derived from structural MRI and systematically validated its reliability using neuroimaging data from over 1,900 individuals, including more than 700 located at six sites in China and around 1,200 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
The study showed that hippocampal radiomic features are related to the clinical features and changes in cognition ability. Long-term follow-up data in some hospitals demonstrated that the markers could be used to track the progression of the disease in high-risk subjects.
The research was published in the journal Science Bulletin.
Liu Yong, one of the researchers, said the research represents a large, interdisciplinary and interinstitutional effort between clinicians and researchers to develop and validate an AD neuroimaging biomarker.
The methodology can be extended to the study of other mental diseases. It has important clinical implications as the biomarker is promising for the early clinical diagnosis or prognostic follow-up in AD, Liu said.
Liu's team has dedicated itself to neuroimaging studies of AD that could provide relevant information to clinical practice.
The team is now focusing on further verification work among people with high risks of AD in more clinical centers, Liu added.
Looking for chemical products? Let suppliers reach out to you!
2026-07-07
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Roche Phase III failure is out? Biogen/Eisai and Eli Lilly seize the AD opportunity
-
An Insight Into The Alzheimer's Breakthrough New Drug
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
Recommend Reading
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
West Asia Tensions Squeeze Pharma Raw Materials
-
₹27,548 Crore Pharma Giant Cipla Enters Weight Management Battle as Obesity Demand Surges
-
BASF Raises API and Excipient Prices
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
-
Covestro Acquires HDI Sites in US and Thailand to Expand Footprint
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
In April, the Chinese marine fuel market saw a significant decline
-
April Domestic Refinery Petroleum Coke Market Trended Downward